We replicated Bachhuber et al.’s (1) finding of a negative association between medical marijuana and opioid overdose deaths from 1999 to 2010. However, the association did not hold when more extensive data through 2017 were analyzed. Had the analysis’ endpoint been between 2008 and 2012, the results would have been comparable to those obtained by Bachhuber et al. However, the association became equivocal in 2013; by 2017 it had reversed such that a study conducted in that year might lead some to conclude that medical cannabis laws were compounding opioid overdose mortality. The Bachhuber et al. Policy that expands access to cannabis based on these findings assumes that (i) the same negative relationship is present at the individual level and (ii) the relationship is causal. When multiple studies using similar methods generate a particular result, and for the first time one of those studies fails to replicate with more extensive data, there are multiple ways to explain the discrepancy. Our expanded analysis does not support the interpretation that broader access to cannabis is associated with lower opioid overdose mortality. The CIs for both recreational cannabis laws and low-THC laws are wide due to the comparatively small number of state/year combinations with these laws. Importantly, the CIs are compatible with a strong positive or strong negative correlation, as well as no correlation. The nonrobustness of the earlier findings also highlights the challenges of controlling scientific messages in controversial policy areas. Corporate actors (e.g., the medical cannabis industry) with deep pockets have substantial ability to promote congenial results, and suffering people are desperate for effective solutions. Cannabinoids have demonstrated therapeutic benefits (13), but reducing population-level opioid overdose mortality does not appear to be among them.
While that shouldn't disqualify these stocks from your portfolio, the companies should have a defined plan for achieving profitability in the future. When companies aren't profitable, their cash position is more important because they might need to raise capital by taking on debt or issuing new shares, which can hurt the stock. Growth opportunities: Growth prospects vary widely, especially when companies are limited by their geography. For example, some Canadian companies can't establish significant U.S. Competitive position: Determine a company's economic moat by researching production capacity (for growers), distribution channels, and partnerships. The medical marijuana market faces several risks. Stricter regulations could be imposed, and markets might not expand as quickly as expected. But the long-term prospects of the medical marijuana industry appear very good. More countries and U.S. More individuals and the broader medical community are also recognizing these potential benefits, driving higher demand for medical marijuana. This presents a terrific opportunity for risk-tolerant investors.
The medicinal uses of cannabis, more commonly known as marijuana, dates back thousands of years. One of the first known uses of cannabis was by the Chinese physician Hoa-tho in the early 2nd century as a surgical anesthesia. Today many experts recognize that medical marijuana (MMJ) and the healing properties of cannabis offer relief for a variety of crippling medical conditions like nausea from chemotherapy, chronic pain, HIV/AIDS, and glaucoma. Are you a candidate for MMJ? Opinions vary from expert to expert, but a common thread emerges when it comes to the benefits of MMJ. The healing properties help many patients cope with their disease by improving the overall quality of their lives. If your medical condition presents these as issues, you may be a good candidate for MMJ. The identified ailments to get a medical marijuana card also vary from state to state. In Colorado, for example, there are eight recognized conditions that a physician may select when recommending approval for a registry card. Don't let this rather narrow list dissuade you in seeking out a medical recommendation. Medical cannabis has been well documented to be effective in the treatment of nausea, PMS, weight loss, Cancer, glaucoma and muscle spasticity. New studies and findings are showing positive results for a whole host of medical conditions including: Chron's disease, fibromyalgia, migraines, multiple sclerosis, and even Tourette Syndrome and obsessive-compulsive disorder. If you suffer from these or like conditions, seek out the recommendation of a qualified physician in your state. Your health and general well-being may be improved by the use of medical marijuana.
At least one dozen states have laws legalizing the use of marijuana for medicinal purposes. In California, the Medical Marijuana Program is operated at the county level, not the state level. In order to obtain a license, you must first find out if your county has any regulations that you must follow in order to obtain it. Typically, one will have to fill out a form and obtain a written recommendation from a physician. It is evident by doing a simple search in Google that a medical marijuana license may be easier to obtain than expected. Since the act was enacted, California has has a significant surge in medical marijuana dispensaries. It is important to know that although the law in California allows the use of medical marijuana, federal law still lists marijuana as an illegal narcotic. Many dispensaries have faced federal criminal charges as a result of federal law. However, with the election of President Obama, dispensary raids that were common during the Bush Administration, have ceased. In California, the laws on penalties for possession of marijuana will differ depending on the quantity possessed. The charges filed, either a felony or a misdemeanor, will depend on the type of crime committed, the type of drug under possession, and the amount of the drug under possession. If you are a repeat offender, or if you have solicited to minors, you may be subject to enhanced criminal charges and sentencing.
Marijuana advocates are hopeful that 2021 could be the year medical marijuana is legalized in North Carolina. Driving the news: The bipartisan NC Compassionate Care Act has gotten further than any other marijuana-related bill with its clearing of the Senate Judiciary committee two weeks ago. Today at 2pm, it will be heard by the Finance committee. The bill still needs to go through two more committees after that before it can get a vote on the Senate floor. Go deeper: Most states now have legal medical marijuana, but N.C. Legal sales won’t start there until 2024, but possession of up to an ounce or four plants per household is legal. The purpose of Virginia’s bill is less about access as it is equity. The July 1 law is rooted in eliminating racist enforcement of simple possession, not to expand access. Because it’s always been accessible, but only certain people have been criminalized for it,” Marijuana Justice founder Chelsea Higgs Wise told the Virginia Mercury. Even without legal sales, a budding new industry has appeared across the border. Cannabar opened in Virginia Beach. The 4,000-square-foot bar and CBD shop allows guests to BYO-marijuana. New businesses like Homegrown VA have launched with the hope of educating people how to grow cannabis at home.
To read more about medical marijuana cards follow the link provided.
ReplyDelete